Oramed Pharmaceuticals Israeli Company
Oramed Pharmaceuticals has developed a proprietary platform technology that allows for the oral delivery of drugs currently administered only via injection. The company's flagship product is an oral insulin capsule that has the potential to better the lives of millions of diabetics worldwide by enabling patients with type 2 diabetes to begin insulin therapy earlier, without needles.
Health Tech & Life Sciences
Biotechnology
Health Care
Medical
Pharmaceutical
Alternatives
No alternatives listed yet.
AI-Generated Alternatives
Powered by AI May contain mistakes
AI is thinking and generating alternatives...
{
$el.querySelectorAll('a').forEach(link => {
link.target = '_blank';
link.rel = 'noopener noreferrer';
});
})"
class="ai-alternatives-content prose prose-sm dark:prose-invert prose-headings:text-gray-900 dark:prose-headings:text-gray-100 prose-p:text-gray-700 dark:prose-p:text-gray-300 prose-strong:text-gray-900 dark:prose-strong:text-gray-100 max-w-none [&>h2]:mb-4 [&>h2]:mt-8 [&>h3]:mb-3 [&>h3]:mt-6 [&>p]:mb-4 [&>ul>li]:my-2 [&>ul]:space-y-3"
>
Suggest an Alternative
Founders
Parent Companies/Investors
Office Locations
Jerusalem, Israel
New York, United States
References
[1]
techaviv.com
- https://www.techaviv.com/people/nadav-kidron
[2]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/oramed-pharmaceuticals
[3]
crunchbase.com
- https://www.crunchbase.com/organization/oramed-pharmaceuticals
External links are provided for reference and verification purposes.